|
End-of-day quote
Nasdaq
2026-10-20
|
5-day change | 1st Jan Change | ||
| 14.06 USD | +11.85% |
|
+19.66% | +7.90% |
| 10-20 | Freenome, Inc. Launches SimpleScreenTM Lung And Personalized Cancer Detection Offering With SimpleScreen CRC | CI |
| 10-20 | Freenome Launches SimpleScreen Lung Cancer Test | MT |
Company Valuation: Freenome, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 144.2 | 1,372 | - | - |
| Change | - | 851.46% | - | - |
| Enterprise Value (EV) | 144.2 | 1,372 | 1,372 | 1,372 |
| Change | - | 851.46% | 0% | 0% |
| P/E | -1.57x | -6.48x | -5.72x | -5.63x |
| PBR | - | - | - | - |
| PEG | - | 0.1x | -0.4x | -3.43x |
| Capitalization / Revenue | - | 13.4x | 12.1x | 6.59x |
| EV / Revenue | - | 13.4x | 12.1x | 6.59x |
| EV / EBITDA | - | 1,525x | -7.76x | -8.23x |
| EV / EBIT | - | -11.8x | -6.39x | -7.99x |
| EV / FCF | - | -10.2x | -8.61x | -23.5x |
| FCF Yield | - | -9.78% | -11.6% | -4.26% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -8.28 | -1.97 | -2.233 | -2.27 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 102.4 | 113.8 | 208.1 |
| EBITDA 1 | - | 0.9 | -176.8 | -166.7 |
| EBIT 1 | - | -116.1 | -214.8 | -171.8 |
| Net income 1 | -219.3 | -175.1 | -245.7 | -257.7 |
| Net Debt | - | - | - | - |
| Reference price 2 | 13.03 | 12.77 | 12.77 | 12.77 |
| Nbr of stocks (in thousands) | 11,068 | 107,447 | - | - |
| Announcement Date | 3/30/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.48x | - | - | - | 1.37B | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 23.45x | 26.46x | 15.68x | 0.32% | 38.45B | |
| Weighted average by Cap. | 26.60x | 25.33x | 15.90x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FRNM Stock
- Valuation Freenome, Inc.
Select your edition
All financial news and data tailored to specific country editions
